Equine ACE2/hFc antibody and antigen (recombinant protein) GMP-EQU-ACE2-hFc

 Download 

Product information

Size： 1mg | 10mg | 100mg

Catalog No.	Description	US $ Price (per mg)	First Order Discount	First Order Discount Price
GMP-EQU-ACE2/hFc-Ag01	Recombinant Equine ACE2/hFc protein	3090
GMP-EQU-ACE2/hFc-Ab01	Anti-Equine ACE2/hFc mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-EQU-ACE2/hFc-Ab02	Anti-Equine ACE2/hFc mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-EQU-ACE2/hFc-Ab03	Anti-Equine ACE2/hFc mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-EQU-ACE2/hFc-Ab04	Anti-Equine ACE2/hFc mouse monoclonal antibody (mAb)	1953	20%	1562.4

Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)

Product Description

Cat No. of Products	GMP-EQU-ACE2/hFc-Ag01
Product Name	Recombinant Equine ACE2/hFc protein
Target/Biomarker	Equine Angiotensin Converting Enzyme 2 (ACE2/hFc)
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Equine Angiotensin Converting Enzyme 2 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in ACE2/hFc level test of animal Equine/Horse with acute respiratory distress syndrome.
Tag	His
Products description	Recombinant Equine ACE2/hFc protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	PBS liquid / Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-EQU-ACE2/hFc-Ab01, GMP-EQU-ACE2/hFc-Ab02, GMP-EQU-ACE2/hFc-Ab03, GMP-EQU-ACE2/hFc-Ab04
Product Name	Anti-Equine ACE2/hFc mouse monoclonal antibody (mAb)
Target/Biomarker	Equine Angiotensin Converting Enzyme 2 (ACE2/hFc)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Anti-Equine Angiotensin Converting Enzyme 2 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in ACE2/hFc level test of animal Equine/Horse with acute respiratory distress syndrome.
Tag	mFc
Products description	Anti-Equine ACE2/hFc mouse monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Equine ACE2/hFc, a fusion protein positioned at the intersection of equine biology and molecular research, represents a milestone in scientific innovation. Comprising two distinct components - Equine ACE2 (Angiotensin-Converting Enzyme 2) and the human immunoglobulin Fc region (hFc) - it offers a multifaceted lens through which to explore the intricacies of equine cardiovascular physiology and its implications for zoonotic research. At its core, Equine ACE2 is a pivotal player in the cardiovascular system of horses. As a membrane-bound metallopeptidase, it governs the conversion of Angiotensin II to Angiotensin 1-7, a transition that exerts potent control over blood pressure, fluid balance, and overall cardiovascular homeostasis in equines. Measuring Equine ACE2/hFc provides researchers with a privileged view into the molecular choreography that underpins equine cardiovascular health. The fusion with the human immunoglobulin Fc region (hFc) is a stroke of molecular genius. It amplifies the versatility of Equine ACE2/hFc by enabling precise detection, purification, and manipulation in laboratory settings. This innovation empowers researchers to dissect the molecular intricacies governing equine ACE2 receptor biology with unparalleled precision, ushering in a new era of equine molecular research. Beyond its utility in unraveling equine physiology, Equine ACE2/hFc assumes a central role in zoonotic research. With the increasing global focus on emerging infectious diseases, particularly exemplified by the COVID-19 pandemic, this fusion protein stands as a sentinel, guiding researchers as they explore the potential role of horses as reservoirs and vectors for zoonotic pathogens. It provides a unique platform to investigate interactions between equine ACE2 receptors and pathogens, offering insights into susceptibility, transmission dynamics, and the development of preventive strategies.

About GDU